Ditan

Ditans are a class of abortive medication for the treatment of migraines.[1]

Ditan
Drug class
Lasmiditan
Class identifiers
UseMigraine
Biological target5-HT1F receptor
In Wikidata

Ditans selectively bind to the 5-HT1F receptor subtype. A number of triptans have been shown to act on this subtype as well, but only after their affinity for 5-HT1B and 5-HT1D has been made responsible for their anti-migraine activity. The lack of affinity for these receptors might result in fewer side effects related to vasoconstriction compared to triptans in susceptible patients, such as those with ischemic heart disease, Raynaud's phenomenon or after a myocardial infarction.[2] A 1998 review has found such side effects to rarely occur in most patients taking triptans.[3][4] The first drug in this class is Eli Lilly's experimental drug lasmiditan.

References
  1. http://adisinsight.springer.com/drugs/800028519
  2. "Molecule of the Month July 2010: Lasmiditan hydrochloride". Prous Science. Retrieved 2011-08-03.
  3. Dahlöf, CG; Mathew, N (1998). "Cardiovascular safety of 5HT1B/1D agonists--is there a cause for concern?". Cephalalgia: An International Journal of Headache. 18 (8): 539–45. doi:10.1046/j.1468-2982.1998.1808539.x. PMID 9827245.
  4. Mutschler, Ernst; Geisslinger, Gerd; Kroemer, Heyo K.; Schäfer-Korting, Monika. Arzneimittelwirkungen. Wissenschaftliche Verlagsgesellschaft.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.